Abstract
The accumulation of amyloidogenic α-synuclein (α-syn) is the prominent marker of Lewy bodies, typically deposited in neurons in Parkinson’s disease (PD) and several other neurodegenerative disorders. Various posttranslational modifications (PTMs), such as O-GlcNAcylation, occur in α-syn. Modification by O-GlcNAcylation effectively hinders α-syn aggregation and attenuates its cellular toxicity in vitro and in vivo. Robust methods are crucial for investigating O-GlcNAc modification of α-syn and understanding its pivotal roles in intricate cellular processes and diseases. Here, we describe biochemical approaches for evaluating the effect of O-GlcNAc modification on the neuronal toxicity of α-syn aggregates and detecting this modification through an enzymatic labeling method. Employing an enzymatic labeling approach to investigate α-syn O-GlcNAcylation also involves attaching defined molecular weights of polyethylene glycol polymers to O-GlcNAcylated proteins. Mass tag installation causes the O-GlcNAcylated proteins to shift upward when separated by SDS-PAGE electrophoresis. The O-GlcNAcylated α-syn protein, with a predictable molecular weight, can be determined using immunoblotting with a specific antibody. This approach enables the identification and distinction of the O-GlcNAcylated and non-O-GlcNAcylated forms of α-syn proteins, thereby allowing the quantification of the conformational fibril α-syn proteins modified by O-GlcNAcylation. These methods may represent a useful strategy for analyzing the posttranslational O-GlcNAc modifications of α-syn protein in various samples.

This publication has 25 references indexed in Scilit: